Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model

Author：              

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.2, Iss.5, 2011-01, pp. : 773-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2

By                  

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2415-2421

Spandidos Publications

Access to resources Recommend Favorite

Continuous administration of recombinant human endostatin (Endostar): A pre-clinical safety study

By            

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 1018-1022

Spandidos Publications

Access to resources Recommend Favorite

Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment

By                      

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2981-2991

Spandidos Publications

Access to resources Recommend Favorite

Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells

By                

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1689-1696

Spandidos Publications

Access to resources Recommend Favorite

Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells

By Yang Qu   Zhang Shanyong   Kang Mingyang   Dong Rongpeng   Zhao Jianwu  

Oncology Reports, Vol. 33, Iss. 5, 2015-05 ,pp. : 2537-2544

Spandidos Publications

Access to resources Recommend Favorite